Literature DB >> 30055039

Pulmonary manifestations in tuberous sclerosis complex.

Nishant Gupta1, Elizabeth P Henske2.   

Abstract

Tuberous sclerosis complex has manifestations in many organ systems, including brain, heart, kidney, skin, and lung. The primary manifestations in the lung are lymphangioleiomyomatosis (LAM) and multifocal micronodular pneumocyte hyperplasia (MMPH). LAM affects almost exclusively women, and causes cystic lung destruction, pneumothorax, and chylous pleural effusions. LAM can lead to dyspnea, oxygen dependence, and respiratory failure, with more rapid disease progression during the premenopausal years. In contrast, MMPH affects men and women equally, causing small nodular pulmonary deposits of type II pneumocytes that rarely progress to symptomatic disease. Here, we review the clinical features and pathogenesis of LAM and MMPH.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  TSC; VEGF-D; lymphangioleiomyomatosis; mTOR; sirolimus

Mesh:

Substances:

Year:  2018        PMID: 30055039      PMCID: PMC6209521          DOI: 10.1002/ajmg.c.31638

Source DB:  PubMed          Journal:  Am J Med Genet C Semin Med Genet        ISSN: 1552-4868            Impact factor:   3.908


  97 in total

1.  Doxycycline treatment for lymphangioleiomyomatosis with urinary monitoring for MMPs.

Authors:  Marsha A Moses; Jay Harper; Judah Folkman
Journal:  N Engl J Med       Date:  2006-06-15       Impact factor: 91.245

Review 2.  Spontaneous pneumothorax in diffuse cystic lung diseases.

Authors:  Joseph Cooley; Yun Chor Gary Lee; Nishant Gupta
Journal:  Curr Opin Pulm Med       Date:  2017-07       Impact factor: 3.155

3.  Exonic mutations of TSC2/TSC1 are common but not seen in all sporadic pulmonary lymphangioleiomyomatosis.

Authors:  Kameswara Rao Badri; Ling Gao; Elizabeth Hyjek; Noa Schuger; Lucia Schuger; Wei Qin; Yvonne Chekaluk; David J Kwiatkowski; Xiaoning Zhe
Journal:  Am J Respir Crit Care Med       Date:  2013-03-15       Impact factor: 21.405

4.  Prognostic significance of pulmonary lymphangioleiomyomatosis histologic score.

Authors:  K Matsui; M B Beasley; W K Nelson; P M Barnes; J Bechtle; R Falk; V J Ferrans; J Moss; W D Travis
Journal:  Am J Surg Pathol       Date:  2001-04       Impact factor: 6.394

5.  Mutational and radiographic analysis of pulmonary disease consistent with lymphangioleiomyomatosis and micronodular pneumocyte hyperplasia in women with tuberous sclerosis.

Authors:  D N Franz; A Brody; C Meyer; J Leonard; G Chuck; S Dabora; G Sethuraman; T V Colby; D J Kwiatkowski; F X McCormack
Journal:  Am J Respir Crit Care Med       Date:  2001-08-15       Impact factor: 21.405

6.  Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs.

Authors:  S L Dabora; S Jozwiak; D N Franz; P S Roberts; A Nieto; J Chung; Y S Choy; M P Reeve; E Thiele; J C Egelhoff; J Kasprzyk-Obara; D Domanska-Pakiela; D J Kwiatkowski
Journal:  Am J Hum Genet       Date:  2000-12-08       Impact factor: 11.025

7.  Pulmonary lymphangioleiomyomatosis in a karyotypically normal man without tuberous sclerosis complex.

Authors:  Mario Schiavina; Valerio Di Scioscio; Paola Contini; Alberto Cavazza; Andrea Fabiani; Marco Barberis; Alessandro Bini; Annalisa Altimari; Robin M T Cooke; Walter F Grigioni; Antonia D'Errico-Grigioni
Journal:  Am J Respir Crit Care Med       Date:  2007-04-12       Impact factor: 21.405

8.  Changes in lung function and chylous effusions in patients with lymphangioleiomyomatosis treated with sirolimus.

Authors:  Angelo M Taveira-DaSilva; Olanda Hathaway; Mario Stylianou; Joel Moss
Journal:  Ann Intern Med       Date:  2011-06-21       Impact factor: 25.391

9.  Pulmonary lymphangioleiomyomatosis in a male patient with tuberous sclerosis complex.

Authors:  Mototaka Miyake; Ukihide Tateishi; Tetsuo Maeda; Masahiko Kusumoto; Mitsuo Satake; Yasuaki Arai; Kazuro Sugimura
Journal:  Radiat Med       Date:  2005-11

10.  Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference.

Authors:  Darcy A Krueger; Hope Northrup
Journal:  Pediatr Neurol       Date:  2013-10       Impact factor: 3.372

View more
  16 in total

1.  IMPDH inhibitors for antitumor therapy in tuberous sclerosis complex.

Authors:  Alexander J Valvezan; Molly C McNamara; Spencer K Miller; Margaret E Torrence; John M Asara; Elizabeth P Henske; Brendan D Manning
Journal:  JCI Insight       Date:  2020-04-09

2.  Generalised mosaicism for TSC2 mutation in isolated lymphangioleiomyomatosis.

Authors:  Barbara Ogórek; Lana Hamieh; Kathryn Lasseter; Shefali Bagwe; Tania Machado; Carmen Herranz-Ors; Aaron R Thorner; Anwesha Nag; Peter Gulleman; Krinio Giannikou; Lisa R Young; Miquel Àngel Pujana; Thomas N Darling; Souheil El-Chemaly; Joel Moss; Elizabeth P Henske; David J Kwiatkowski
Journal:  Eur Respir J       Date:  2019-10-10       Impact factor: 16.671

3.  Construction of TSC2 knockout cell line using CRISPR/Cas9 system and demonstration of its effects on NIH-3T3 cells.

Authors:  Xu Wang; Yang Zhao; Zhan Wang; Zhangcheng Liao; Yushi Zhang
Journal:  Cell Biochem Biophys       Date:  2022-10-01       Impact factor: 2.989

4.  Analysis of Clinical Features and Next-Generation Sequencing of 12 Tuberous Sclerosis Families in China.

Authors:  Xu Wang; Wenda Wang; Yang Zhao; Zhan Wang; Yushi Zhang
Journal:  Front Med (Lausanne)       Date:  2022-05-27

Review 5.  Monitoring and Managing Patients with Tuberous Sclerosis Complex: Current State of Knowledge.

Authors:  Inês Gomes; Joana Jesus Ribeiro; Filipe Palavra
Journal:  J Multidiscip Healthc       Date:  2022-07-14

6.  Therapeutic Targeting of the Secreted Lysophospholipase D Autotaxin Suppresses Tuberous Sclerosis Complex-Associated Tumorigenesis.

Authors:  William J Mischler; Ashish C Gurung; You Feng; Taylor R Kavanagh; Grigoriy Androsov; Peter M Sadow; Zachary T Herbert; Carmen Priolo
Journal:  Cancer Res       Date:  2020-05-11       Impact factor: 12.701

Review 7.  Recognizing genetic disease: A key aspect of pediatric pulmonary care.

Authors:  Lael M Yonker; Megan H Hawley; Peter P Moschovis; Mengdi Lu; T Bernard Kinane
Journal:  Pediatr Pulmonol       Date:  2020-07

Review 8.  The future is here: Integrating genetics into the pediatric pulmonary clinic.

Authors:  Megan H Hawley; Peter P Moschovis; Mengdi Lu; T Bernard Kinane; Lael M Yonker
Journal:  Pediatr Pulmonol       Date:  2020-07

Review 9.  Cutaneous Expression of Familial Cancer Syndromes.

Authors:  Anne-Johanne Andersen; Juliane Schierbeck; Anette Bygum; Nieves Puente-Pablo
Journal:  Acta Derm Venereol       Date:  2021-07-30       Impact factor: 3.875

10.  Bronchial angiofibroma in tuberous sclerosis complex: A case report and literature review.

Authors:  Peikun Teng; Jing Liu; Deshun Liu; Wenfei Li; Xuedong Liu
Journal:  Am J Med Genet A       Date:  2021-07-10       Impact factor: 2.578

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.